Renaissance of Minilaparoscopy in the NOTES and Single Port Era

Not every great product becomes a blockbuster. Not every new technology, as promising as it may be, will be used on a large scale. Some features are critical to the success of a new technology over the competitive already established ones. Surgeons are but consumers in this rapidly changing world, deciding which new technology/technique they will adopt: NOTES (Natural Orifice Transluminal Endoscopic Surgery), LESS (LaparoEndoscopic Single Site Surgery), or Minilaparoscopy. A general availability with few access limitations, easy applicability with a short learning curve and a superior benefit to cost ratio ensures whether a technique survives for posterity. Lastly, without direct and substantial benefit to the patient, any new technique or technology would ultimately be consigned to the flames of history. The final arbiter obviously is the end consumer the patient for whose benefit all this is explored.